Search

You searched for "foundation"

2786 results found

Ophthalmology Scholarship Applications Open – Deadline 1 June 2021

25 January 2021
The University of Edinburgh has opened applications for The David and Molly Pyott Foundation Scholarships in Ophthalmology which will support eligible ophthalmology trainees / registrars /residents undertake the university’s online, two-year, part-time ChM (Master of Surgery) in Clinical Ophthalmology from September 2021.

Navigating an Ophthalmology Lab-Based Research Elective: Reflections and Insights from Johns Hopkins Wilmer Eye Institute

10 November 2025 | | EYE - Cornea
Medical school electives offer valuable opportunities to gain exposure to different healthcare systems and bridge specific gaps in training. While clinical electives are often the primary choice for medical students, research-focused electives also present unique benefits, particularly for those interested...
Ophthalmologica journal front cover image.

Comparison of the efficacy of anti-VEGFs agents in nvAMD

1 June 2026 | | EYE - Vitreo-Retinal
This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...

UK Eye Genetics Group (UK-EGG) 2024

10 June 2024
by Mohammed Aslam, FY 3 Doctor, Calderdale and Huddersfield NHS Foundation Trust, UK. Founded in 2002, the UK EGG provides a hub to share knowledge on inherited eye disease and train the next generation of clinicians and scientists. This year’s...

World Sight Day 2026: An important milestone toward eye care for all

13 July 2026 | global
IAPB has launched its 2026 campaign for World Sight Day with a call for the eye health sector to once again unite behind the global movement to #LoveYourEyes. Building on the success of the last five years, the campaign continues...

UK’s leading sight loss charity, RNIB, appoints five new trustees

9 July 2026 | charity
The Royal National Institute of Blind People (RNIB) has appointed five new trustees to its board. The new additions bring a wealth of experience and will play a crucial role in making major decisions that affect the charity and its...

First NHS Trust in North East of England achieves prestigious RNIB employment accessibility award

8 August 2026 | charity, awards
South Tyneside and Sunderland NHS Foundation Trust has become the first NHS Trust in the north east of England to achieve the Royal National Institute of Blind People’s (RNIB) Visibly Better Employer Standard (VBE). The Trust, which runs a major...

Should points for simulated surgery be removed from the ophthalmology ST1 evidence folder?

2 April 2025 | | EYE - General
The benefits of the Eyesi surgical simulator by Haag-Streit UK for early career ophthalmology speciality trainees are well-established, allowing for the practice of cataract and vitreoretinal surgery in a controlled, risk-free environment. Whilst the Eyesi is an invaluable resource for...

Gene Vision launched to support those diagnosed with genetic eye diseases

2 December 2020
A new website, Gene Vision (https://gene.vision), has been developed by Professor Mariya Moosajee and Dr Alex Yeong, supported by Dr Peter Thomas (Director of Digital Innovation at Moorfields Eye Hospital). The new site is intended for adults, children and their families who are diagnosed with rare genetic eye diseases.

Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics

9 May 2025 | AI, Artificial intelligence, oculomics, news, Moorfields, Cascader, imaging, industry news
Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...

Effective treatment for rare sight-threatening infection

1 November 2023 | Moorfields, UCL, SIFI S.p.A., Acanthamoeba, keratitis, corneal infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

A guide to utilising your time efficiently to develop clinical and procedural skills as an aspiring ophthalmologist

4 February 2025 | | EYE - General
Ophthalmology often receives limited coverage in the undergraduate medical curriculum, and the availability of foundation programme jobs in this field is also restricted, reducing exposure to this field for aspiring ophthalmologists. Even if you’re not planning to specialise in ophthalmology,...